EMEA Should Adopt More FDA Methods To Speed Drug Approval - CPMP Chair
Executive Summary
The European Medicines Evaluation Agency should consider the adoption of more FDA-style mechanisms to speed approval of important new drugs, Commission for Proprietary Medicinal Products Chairman Jean-Michel Alexandre, PhD, indicated.
You may also be interested in...
Swedish Regulatory Agency Deputy Director Lonngren Will Head EMEA
Swedish Medical Products Agency Deputy Director Thomas Lonngren will try to maintain the performance and acceptance levels of the EMEA following the departure of the agency's first director, Fernand Sauer.
Swedish Regulatory Agency Deputy Director Lonngren Will Head EMEA
Swedish Medical Products Agency Deputy Director Thomas Lonngren will try to maintain the performance and acceptance levels of the EMEA following the departure of the agency's first director, Fernand Sauer.
EU Orphan Designations Expected By Third Quarter; 24 Applications Received
EMEA's Committee for Orphan Medicinal Products expects to deliver its first orphan drug designations by the third quarter of this year, the committee said.